Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort.
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F.
Halfon P, et al.
Antivir Ther. 2018;23(4):307-314. doi: 10.3851/IMP3184.
Antivir Ther. 2018.
PMID: 28730994